The NQO1 Pro187Ser Polymorphism and Breast Cancer Susceptibility: Evidence from an Updated Meta-analysis

Overview

Journal Diagn Pathol

Publisher Biomed Central

Specialty Pathology

Date 2014 Jun 3

PMID 24884893

Citations 14

Authors

Qiliu Peng

Yu Lu

Xianjun Lao

Zhiping Chen

Ruolin Li

Jingzhe Sui

Xue Qin

Shan Li

Affiliations

Soon will be listed here.

Abstract

Background Nad(p)h: quinone oxidoreductase 1 (NQO1) plays a central role in catalyzing the two-electron reduction of quinoid compounds into hydroquinones. The NQO1 Pro187Ser polymorphism was found to correlate with a lower enzymatic activity, which may result in increased incidence of carcinomas including breast cancer. Previous studies investigating the association between NQO1 Pro187Ser polymorphism and breast cancer risk showed inconsistent results. We performed a meta-analysis to summarize the possible association.

Methods: All studies published from January 1966 to February 2014 on the association between NQO1 Pro187Ser polymorphism and breast cancer risk were identified by searching electronic databases PubMed, EMBASE, Cochrane library, and Chinese Biomedical Literature database (CBM). The association between NQO1 Pro187Ser polymorphism and breast cancer risk was assessed by odds ratios (ORs) together with their 95% confidence intervals (CIs).

Results: Ten studies with 2,773 cases and 4,076 controls were finally included in the meta-analysis. We did not observe a significant association between NQO1 Pro187Ser polymorphism and breast cancer risk when all studies were pooled into the meta-analysis. In subgroup analysis by ethnicity, significant increased breast cancer risk was found in Caucasians (Ser/Pro vs. Pro/Pro: OR=1.145, 95% CI=1.008-1.301, P=0.038; Ser/Ser+Ser/Pro vs. Pro/Pro: OR=1.177, 95% CI=1.041-1.331, P=0.009). When stratified by source of control, significant increased breast cancer risk was found in population-based studies (Ser/Pro vs. Pro/Pro: OR=1.180, 95% CI=1.035-1.344, P=0.013; Ser/Ser+Ser/Pro vs. Pro/Pro: OR=1.191, 95% CI=1.050-1.350, P=0.007). However, in subgroup analyses according to menopausal status, quality score, and HWE in controls, no any significant association was detected.

Conclusions: Our meta-analysis provides the evidence that the NQO1 Pro187Ser polymorphism contributed to the breast cancer susceptibility among Caucasians. Further large and well-designed studies are needed to confirm this association.

Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1248639991252504.

Citing Articles

Role of NADPH Quinone Reductase 1 (NQO1) Polymorphism in Prevention, Diagnosis, and Treatment of Gastrointestinal Cancers.

Ghorbani F, Mazidimoradi A, Biyabani A, Allahqoli L, Salehiniya H Curr Cancer Drug Targets. 2024; 24(12):1213-1221.

PMID: 38318828 DOI: 10.2174/0115680096283149240109094710.

Impact of NQO1 dysregulation in CNS disorders.

Yuhan L, Khaleghi Ghadiri M, Gorji A J Transl Med. 2024; 22(1):4.

PMID: 38167027 PMC: 10762857. DOI: 10.1186/s12967-023-04802-3.

NQO1/CPT1A promotes the progression of pancreatic adenocarcinoma via fatty acid oxidation.

Xu R, Liu Y, Ma L, Sun Y, Liu H, Yang Y Acta Biochim Biophys Sin (Shanghai). 2023; 55(5):758-768.

PMID: 37249337 PMC: 10281888. DOI: 10.3724/abbs.2023066.

Genetic Polymorphism of NQO1 Gene is Associated with Susceptibility of Ischemic Stroke in Chinese Han Nationality.

Yan L, Xu D, Xiao Y, Dai M, Wang T, Zhuang X Neuropsychiatr Dis Treat. 2022; 18:2211-2217.

PMID: 36196359 PMC: 9527027. DOI: 10.2147/NDT.S379742.

ROS‑associated mechanism of different concentrations of pinacidil postconditioning in the rat cardiac Nrf2‑ARE signaling pathway.

Chen W, Deng M, Wang H, Wang Y, Zhou W, Yu T Mol Med Rep. 2021; 23(6).

PMID: 33846798 PMC: 8060791. DOI: 10.3892/mmr.2021.12072.

References

Sarmanova J, Susova S, Gut I, Mrhalova M, Kodet R, Adamek J . Breast cancer: role of polymorphisms in biotransformation enzymes. Eur J Hum Genet. 2004; 12(10):848-54. DOI: 10.1038/sj.ejhg.5201249. View

Wang Z, Zhang Y, Kong X, Li S, Hu Y, Wang R . Association of a polymorphism in PON-1 gene with steroid-induced osteonecrosis of femoral head in Chinese Han population. Diagn Pathol. 2013; 8:186. PMC: 4226244. DOI: 10.1186/1746-1596-8-186. View

Ma L, Zhao J, Li T, He Y, Wang J, Xie L . Association between tumor necrosis factor-alpha gene polymorphisms and prostate cancer risk: a meta-analysis. Diagn Pathol. 2014; 9:74. PMC: 3977697. DOI: 10.1186/1746-1596-9-74. View

Hong C, Ambrosone C, Ahn J, Choi J, McCullough M, Stevens V . Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2007; 16(9):1784-94. DOI: 10.1158/1055-9965.EPI-07-0247. View

Hamajima N, Matsuo K, Iwata H, Shinoda M, Yamamura Y, Kato T . NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese. Int J Clin Oncol. 2002; 7(2):103-8. DOI: 10.1007/s101470200013. View

Moran J, Siegel D, Ross D . A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity. Proc Natl Acad Sci U S A. 1999; 96(14):8150-5. PMC: 22203. DOI: 10.1073/pnas.96.14.8150. View

Menzel H, Sarmanova J, Soucek P, Berberich R, Grunewald K, Haun M . Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations. Br J Cancer. 2004; 90(10):1989-94. PMC: 2410282. DOI: 10.1038/sj.bjc.6601779. View

Siegel D, Yan C, Ross D . NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones. Biochem Pharmacol. 2012; 83(8):1033-40. PMC: 3482497. DOI: 10.1016/j.bcp.2011.12.017. View

Ioannidis J, Patsopoulos N, Evangelou E . Uncertainty in heterogeneity estimates in meta-analyses. BMJ. 2007; 335(7626):914-6. PMC: 2048840. DOI: 10.1136/bmj.39343.408449.80. View

10.

Mantel N, Haenszel W . Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22(4):719-48. View

11.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

12.

Siegelmann-Danieli N, Buetow K . Significance of genetic variation at the glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase 1 detoxification genes in breast cancer development. Oncology. 2002; 62(1):39-45. DOI: 10.1159/000048245. View

13.

Zhang Y, Liu L, Tang Y, Chen C, Wang Q, Xu J . Polymorphisms in TP53 and MDM2 contribute to higher risk of colorectal cancer in Chinese population: a hospital-based, case-control study. Mol Biol Rep. 2012; 39(10):9661-8. DOI: 10.1007/s11033-012-1831-5. View

14.

Aston C, Ralph D, Lalo D, Manjeshwar S, Gramling B, DeFreese D . Oligogenic combinations associated with breast cancer risk in women under 53 years of age. Hum Genet. 2004; 116(3):208-21. DOI: 10.1007/s00439-004-1206-7. View

15.

Xu Z, Yu L, Zhang X . Association between the hOGG1 Ser326Cys polymorphism and lung cancer susceptibility: a meta-analysis based on 22,475 subjects. Diagn Pathol. 2013; 8:144. PMC: 3853705. DOI: 10.1186/1746-1596-8-144. View

16.

Lajin B, Sakur A, Alachkar A . Association between polymorphisms in apoptotic genes and susceptibility for developing breast cancer in Syrian women. Breast Cancer Res Treat. 2013; 138(2):611-9. DOI: 10.1007/s10549-013-2467-4. View

17.

Dinkova-Kostova A, Talalay P . NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Arch Biochem Biophys. 2010; 501(1):116-23. PMC: 2930038. DOI: 10.1016/j.abb.2010.03.019. View

18.

Rosvold E, McGlynn K, Lustbader E, Buetow K . Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking. Pharmacogenetics. 1995; 5(4):199-206. DOI: 10.1097/00008571-199508000-00003. View

19.

Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin. 2011; 61(2):69-90. DOI: 10.3322/caac.20107. View

20.

Singh V, Upadhyay G, Rastogi N, Singh K, Singh M . Polymorphism of xenobiotic-metabolizing genes and breast cancer susceptibility in North Indian women. Genet Test Mol Biomarkers. 2011; 15(5):343-9. DOI: 10.1089/gtmb.2010.0197. View